Vinci Partners Investments Ltd.'s Q4 2024 results are complex due to merger-related expenses and one-time revenues but show ...
Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute ...
TULIKIVI CORPORATION FINANCIAL STATEMENTS RELEASE 7 MARCH 2025 AT 1 PM - The Tulikivi Group’s net sales were EUR 8.4 million (EUR 9.9 million, 10–12/2023) in the fourth quarter and EUR 33.3 million ...
(Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood’s balance sheet ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results